59.74 USD
↗ 2.96 (5.21%)AT CLOSE (11:59 AM EDT)
Xenon Pharmaceuticals Inc
XENENASDAQ • USD
60.14
↗ 0.40 (0.66%)
POST MARKET (AS OF 04:55 PM EDT)
Post Market
AS OF 04:55 PM EDT
60.14
↗ 0.40 (0.66%)
Market: CLOSED
Xenon Pharmaceuticals Inc (XENE) is currently trading at $59.74. XENE shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, XENE trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 26, 2026.
Open?$56.97
High?$60.32
Low?$56.80
Prev. Close?$56.78
Volume?8.8M
Avg. Volume?1.6M
VWAP?$58.63
Rel. Volume?5.46x
Bid / Ask
Bid?$48.37 × 100
Ask?$73.51 × 100
Spread?$25.14
Midpoint?$60.94
Valuation & Ratios
Market Cap?5.8B
Shares Out?96.7M
Float?68.7M
Float %?88.9%
P/E Ratio?N/A
P/B Ratio?4.32
EPS?-$3.96
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Employees
370
Market Cap
5.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-11-05
Address
200 - 3650 GILMORE WAY
BURNABY,
Phone: (604) 484-3300
BURNABY,
Phone: (604) 484-3300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?44
Piotroski F-Score?0/9Weak
Altman Z-Score?69.31Safe
Confidence?49%Low
Short InterestElevated
Short % of Float?6.42%Elevated
Short Interest?4.4M
Days to Cover?3.2
Free Float68.7M
Avg Daily Volume1.4M
Settlement Date2026-06-15
Financial Health
Current Ratio?27.79Strong
Quick Ratio?27.79Strong
Cash Ratio?13.71Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.32FAIR▾
Peers100
S&P42
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-12.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-28.6%WEAK▾
S&P6
ROA?-27.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-307252000
Enterprise Value?$5.2B
Fundamentals ratios updated end of day